- Section 1 ICU organization and management
- Section 2 Pharmacotherapeutics
- Section 3 Resuscitation
- Section 4 The respiratory system
- Section 5 The cardiovascular system
- Section 6 The gastrointestinal system
- Section 7 Nutrition
- Section 8 The renal system
- Section 9 The neurological system
- Section 10 The metabolic and endocrine systems
- Section 11 The haematological system
- Part 11.1 Laboratory monitoring
- Part 11.2 Haematological therapies
- Part 11.3 Disordered coagulation
- Chapter 269 Pathophysiology of disordered coagulation
- Chapter 270 Disseminated intravascular coagulation in the critically ill
- Chapter 271 Prevention and management of thrombosis in the critically ill
- Chapter 272 Thrombocytopenia in the critically ill
- Part 11.4 Disorders of the blood cells
- Section 12 The skin and connective tissue
- Section 13 Infection
- Section 14 Inflammation
- Section 15 Poisoning
- Section 16 Trauma
- Section 17 Physical disorders
- Section 18 Pain and sedation
- Section 19 General surgical and obstetric intensive care
- Section 20 Specialized intensive care
- Section 21 Recovery from critical illness
- Section 22 End-of-life care
(p. 1292) Prevention and management of thrombosis in the critically ill
- Chapter:
- (p. 1292) Prevention and management of thrombosis in the critically ill
- Author(s):
Chee M. Chan
and Andrew F. Shorr
- DOI:
- 10.1093/med/9780199600830.003.0271
Venous thromboembolism (VTE) represents a significant challenge in the care of critically-ill patients. Because of a combination of factors including comorbidities, their acute illness, and medical interventions, patients in the intensive care unit (ICU) face a heightened risk for VTE. In addition, because of their impaired physiological reserves, critically-ill subjects will not tolerate events, such as pulmonary emboli (PEs), well. A number of recent studies better describe the epidemiology and outcomes related to VTE acquired in the ICU. New research also explores optimal approaches for VTE prevention and better defines the risk for bleeding associated with pharmacological preventive options. This chapter reviews the epidemiology of, outcomes related to, and preventive strategies for VTE in the ICU. It also discusses diagnostic options in addition to focusing on selected populations at very high risk for VTE in the ICU, namely trauma patients and those who have suffered a stroke.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Section 1 ICU organization and management
- Section 2 Pharmacotherapeutics
- Section 3 Resuscitation
- Section 4 The respiratory system
- Section 5 The cardiovascular system
- Section 6 The gastrointestinal system
- Section 7 Nutrition
- Section 8 The renal system
- Section 9 The neurological system
- Section 10 The metabolic and endocrine systems
- Section 11 The haematological system
- Part 11.1 Laboratory monitoring
- Part 11.2 Haematological therapies
- Part 11.3 Disordered coagulation
- Chapter 269 Pathophysiology of disordered coagulation
- Chapter 270 Disseminated intravascular coagulation in the critically ill
- Chapter 271 Prevention and management of thrombosis in the critically ill
- Chapter 272 Thrombocytopenia in the critically ill
- Part 11.4 Disorders of the blood cells
- Section 12 The skin and connective tissue
- Section 13 Infection
- Section 14 Inflammation
- Section 15 Poisoning
- Section 16 Trauma
- Section 17 Physical disorders
- Section 18 Pain and sedation
- Section 19 General surgical and obstetric intensive care
- Section 20 Specialized intensive care
- Section 21 Recovery from critical illness
- Section 22 End-of-life care